Literature DB >> 27790444

Amyloidosis: The Newer Discovered ALECT2 Associated with der7q add(7).

Amrita Chakrabarti1, Priyanka Samal2, Joydeep Chakrabartty3.   

Abstract

Amyloidosis is characterized by pathological deposition of abnormal protein aggregates in various tissues, AL protein being the commonest. ALECT 2 is the newest protein described, having a predisposition to affect the kidneys, sometimes the liver and rarely other organs. We present a case of renal amyloid ALECT 2 due to leucocyte cell derived chemotaxin 2, a novel amyloidogenic protein. The patient presented with mild proteinuria, scattered plasma cells on bone marrow examination and altered kappa/lambda ratio with associated cytogenetic abnormality of der7q add(7). It is essential to correctly type this protein and differentiate it from AL during diagnosis for appropriate and effective clinical management.

Entities:  

Keywords:  AL Protein; Leucocyte derived chemotaxin 2; Renal amyloidosis; der7q add(7)

Year:  2016        PMID: 27790444      PMCID: PMC5071944          DOI: 10.7860/JCDR/2016/21705.8555

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis.

Authors:  Samar M Said; Sanjeev Sethi; Anthony M Valeri; Anthony Chang; Cynthia C Nast; Leslie Krahl; Peter Molloy; Marc Barry; Mary E Fidler; Lynn D Cornell; Nelson Leung; Julie A Vrana; Jason D Theis; Ahmet Dogan; Samih H Nasr
Journal:  Kidney Int       Date:  2014-01-22       Impact factor: 10.612

2.  Leukocyte Derived Chemotaxin 2 (ALECT2) Amyloidosis.

Authors:  Uday Kulkarni; Anna Valson; Anila Korula; Vikram Mathews
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-07-01       Impact factor: 2.576

3.  Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis.

Authors:  Christopher P Larsen; Robert J Kossmann; Marjorie L Beggs; Alan Solomon; Patrick D Walker
Journal:  Kidney Int       Date:  2014-02-12       Impact factor: 10.612

4.  Genes for serum amyloid A proteins map to Chromosome 7 in the mouse.

Authors:  B A Taylor; L Rowe
Journal:  Mol Gen Genet       Date:  1984

5.  ALECT2 amyloidosis: a new type of systemic amyloid highly prevalent in the Hispanic population.

Authors:  Víctor H Jiménez-Zepeda; Nelson Leung
Journal:  Rev Invest Clin       Date:  2014 May-Jun       Impact factor: 1.451

6.  Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series.

Authors:  Charles L Murphy; Shuching Wang; Daniel Kestler; Christopher Larsen; Don Benson; Deborah T Weiss; Alan Solomon
Journal:  Am J Kidney Dis       Date:  2010-10-16       Impact factor: 8.860

7.  Chromosomal abnormalities in systemic amyloidosis.

Authors:  R Fonseca; G J Ahmann; S M Jalal; G W Dewald; D R Larson; T M Therneau; M A Gertz; R A Kyle; P R Greipp
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

8.  Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor.

Authors:  J Vela-Ojeda; M A García-Ruiz Esparza; Y Padilla-González; E Sánchez-Cortes; J García-Chávez; L Montiel-Cervantes; E Reyes-Maldonado; A Majluf-Cruz; H Mayani
Journal:  Ann Hematol       Date:  2008-07-22       Impact factor: 3.673

9.  How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing.

Authors:  Nelson Leung; Samih H Nasr; Sanjeev Sethi
Journal:  Blood       Date:  2012-09-04       Impact factor: 22.113

  9 in total
  1 in total

1.  Leukocyte chemotactic factor 2-related amyloidosis presenting with severe jaundice and hepatic encephalopathy.

Authors:  Hussam Almasri; Almurtada Razok; Ahmed Badi; Muneera Almohannadi; Abdo Lutf; Mahir Petkar; Abdelnaser Elzouki
Journal:  Clin Case Rep       Date:  2021-12-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.